no answer left message

follow up form submitted, no changes in medical history, not lost any weight in the last 4 weeks, no side effects, dose increase prescription for Wegovy 1mg issued

doing well on medication, no side effects, managing injections well, no changes in medical history, happy to continue on medication, appetite up an down, dose increase, next pen Wegovy 0.5mg prescription issued

left message

doing well on medication ,manages injections ok, slight diahorrea ,no other side effects, advice given on management, according to own scale lost 5ibs, follow up call booked next week

left message

The client's medical history was reviewed in full, and no contraindications to treatment were identified.

The client is currently taking hormone replacement therapy (HRT) and cholecalciferol. Their current weight is 71 kg, height is 1.60 m, and BMI is 27.7 kg/m². Waist circumference measures 96 cm, indicating central obesity.

The client reports struggling to lose weight since the onset of menopause despite lifestyle measures. They expressed a desire to lose approximately 6–9 kg to improve their overall health and wellbeing. Based on the clinical assessment, the client is considered suitable for prescription weight management treatment.

The available prescription treatment options were discussed in detail, including their benefits, risks, expected outcomes, and potential side effects. Following an informed discussion, the client elected to commence treatment with Wegovy (semaglutide) injections.

The common and serious potential side effects of Wegovy were explained, and the client demonstrated understanding. Comprehensive counselling was provided on the correct use of the Wegovy pen, including administration technique, dose schedule, storage, and disposal of needles.

A prescription for Wegovy 0.25 mg pen was issued. A follow-up telephone review has been booked to assess tolerability, adherence, and treatment response. The client's GP has been notified of the treatment plan and prescription.

client BMI 27 with waist circumference 82cm (central adiposity) suitable for treatment